Ambulatory Versus Home Blood Pressure Monitoring in Obstructive Sleep Apnea

University of Athens50 enrolled

Overview

Subjects referred to a sleep clinic had polysomnography (PSG), clinic BP measurements, 24-hour ABP monitoring and HBP monitoring using a device (Microlife WatchBP HomeN) that allows daytime (3 days, 2 duplicate readings/day) and automated nighttime BP measurement (3 nights, 3 readings/night).

Study Type

OBSERVATIONAL

Enrollment

Conditions

Obstructive Sleep Apnoea Hypertension

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age ≤ 65 years * Suspected OSA * Treated or untreated for hypertension Exclusion Criteria: * History of cardiovascular disease (heart failure, coronary heart disease, arrhythmia or stroke) * History of asthma or chronic obstructive pulmonary disease (FEV1/FVC \<70%) * History of diabetes mellitus, collagen diseases and sarcoidosis * Serum creatinine \>1.6 mg/dl, proteinuria * Previous treatment with CPAP * Pregnancy or menstruation during the study * Treatment with steroids, lithium or any other drugs affecting BP * Change in antihypertensive treatment(if any) in the last 8 weeks before study entry

Locations (2)

First University Department of Respiratory Medicine, Sotiria Hospital

Athens, Greece

RECRUITING

Hypertension Center, Third Department of Medicine, University of Athens, Greece

Athens, Greece

RECRUITING

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.